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 Membrane endoglin (Eng) is a transmembrane glycoprotein that acts as a co-receptor in 
the transforming growth factor β (TGFβ) signalling cascade. Its expression and function have 
been extensively studied predominantly in relation to endothelial function under various 
pathological conditions, including hypercholesterolemia and atherogenesis. However, its role 
in the development of endothelial dysfunction remains controversial. Eng contributes to the 
formation of nitric oxide (NO) and is crucial in in vivo conditions for the development of the 
cardiovascular system and especially the heart. On the other hand, it may play an important role 
in inflammatory adhesion and transmigration of leukocytes to the endothelium, thus 
contributing to the development of endothelial dysfunction as the first stage of atherogenesis. 
 Experiments on endothelial cells isolated from various blood vessels are used to study 
short-term effects of substances and drugs on the endothelium. One of the effects studied in 
endothelial cell cultures is the ability of the substance to induce endothelial dysfunction.  
Endothelial dysfunction is defined in in vitro conditions as a state with increased expression of 
adhesion molecules and increased adhesion and transmigration of immune cells through the 
endothelial monolayer.  
 The aim of this dissertation thesis is to investigate the effects of soluble endoglin (sEng), 
oxidized cholesterol, and selected macrophage secretes on the vascular endothelium. The main 
focus is on monitoring the membrane endoglin (Eng) expression and the expression of 
individual members of its signalling cascade and the expression of pro-inflammatory 
biomarkers of endothelial dysfunction in relation to the development of endothelial dysfunction 
in vitro. 
 Firstly, we investigated the role of sEng in the process of endothelial dysfunction 
development. Human umbilical vein endothelial cells (HUVEC) were treated with two different 
doses of sEng (40 or 500 ng / mL) for 16 hours. We demonstrated the induction of inflammatory 
response by increased activity of nuclear factor kappa B (NF-κB) and interleukin-6 (IL-6) and 
an increase in membrane endoglin expression. This suggests to pro-inflammatory effects of 
soluble endoglin and a significant role of membrane Eng in the early stages of endothelial 
dysfunction development. 
 Subsequently, we focused on the role of Eng in the development of oxidized cholesterol-
induced endothelial dysfunction. In this case, we used human aortic endothelial cells (HAEC) 
pretreated with various oxidized cholesterols (oxysterols). Preliminary experiments showed 
that only 7-ketocholesterol (7K) was able to induce endothelial dysfunction. 7K was able to 
increase the expression of adhesion molecules and Eng as well as increase adhesion and 
transmigration of monocytes through the endothelial monolayer. The decrease in Eng 
expression through gene silencing resulted in decreased adhesion and transmigration of 
monocytes across the monolayer. The results of this study emphasize the crucial role of Eng in 
the development of endothelial dysfunction under in vitro conditions. 
 Finally, we focused on the effect of reduced Eng on the surface of endothelial cells. 
HUVECs were incubated in medium containing macrophage-derived matrix metalloproteinase 
12 (MMP12). MMP12 was able to cleave Eng from the cell surface, resulting in the 
development of endothelial dysfunction characterized by the reduced ability of cells to form 
vessels and heal wounds under in vitro conditions.  
 The results of this dissertation thesis confirm the importance of physiological expression 
of membrane endoglin by endothelial cells and suggest that altered Eng expression may lead to 
the development of pathological changes in the vascular endothelium. 
 
 
